These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 9122968)
1. Treatment of metabolic disorders with fluvastatin after renal transplantation. Podder H; Gerõ L; Földes K; Szabó J; Lazar N; Járay J Transplant Proc; 1997; 29(1-2):216-9. PubMed ID: 9122968 [No Abstract] [Full Text] [Related]
2. The efficacy and safety of fluvastatin in hypercholesterolemia in renal transplant recipients. Ghods AJ; Milanian I; Arghani H; Ghadiri G Transplant Proc; 1995 Oct; 27(5):2579-80. PubMed ID: 7482835 [No Abstract] [Full Text] [Related]
3. Impact of fluvastatin on hyperlipidemia after renal transplantation. Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of treatment with low-dose fluvastatin in hypercholesterolemic renal transplant recipients. Akiyama T; Ishii T; Imanishi M; Nishioka T; Matsuura T; Kurita T Transplant Proc; 2001 May; 33(3):2115-8. PubMed ID: 11377469 [No Abstract] [Full Text] [Related]
5. [Effects of long acting fluvastatin on parameters of lipid metabolism in patients with type 2 diabetes and combined hyperlipidemia]. Kozlov SG; Liakishev AA; Titov VN; Naumov VG Kardiologiia; 2004; 44(10):60-3. PubMed ID: 15477793 [No Abstract] [Full Text] [Related]
6. Fluvastatin in renal transplantation. Hadjigavriel M; Kyriakides G Transplant Proc; 1997 Nov; 29(7):3050. PubMed ID: 9365661 [No Abstract] [Full Text] [Related]
7. A preliminary report of the safety and efficacy of fluvastatin for hypercholesterolemia in renal transplant patients receiving cyclosporine. Goldberg RB; Roth D Am J Cardiol; 1995 Jul; 76(2):107A-109A. PubMed ID: 7604782 [TBL] [Abstract][Full Text] [Related]
8. Effects of fluvastatin on hyperlipidemia after renal transplantation: influence of steroid therapy. Austen JL; Shifrin FA; Bartucci MR; Knauss TC; Schulak JA; Hricik DE Ann Pharmacother; 1996 Dec; 30(12):1386-9. PubMed ID: 8968448 [TBL] [Abstract][Full Text] [Related]
9. The effect of fluvastatin of hyperlipidemia in renal transplant recipients: a prospective, placebo-controlled study. Türk S; Yildiz A; Tükek T; Akkaya V; Aras U; Türkmen A; Uras AR; Sever MS Int Urol Nephrol; 2001; 32(4):713-6. PubMed ID: 11989571 [TBL] [Abstract][Full Text] [Related]
10. Fluvastatin with and without niacin for hypercholesterolemia. Jacobson TA; Chin MM; Fromell GJ; Jokubaitis LA; Amorosa LF Am J Cardiol; 1994 Jul; 74(2):149-54. PubMed ID: 8023779 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of fluvastatin in patients with non-insulin-dependent diabetes mellitus and hyperlipidemia. Knopp RH; Frohlich J; Jokubaitis LA; Dawson K; Broyles FE; Gomez-Coronado D Am J Med; 1994 Jun; 96(6A):69S-78S. PubMed ID: 8017470 [TBL] [Abstract][Full Text] [Related]
12. Effect of fluvastatin on lipoprotein profiles in treating renal transplant recipients with dyslipoproteinemia. Li PK; Mak TW; Chan TH; Wang A; Lam CW; Lai KN Transplantation; 1995 Oct; 60(7):652-6. PubMed ID: 7570971 [TBL] [Abstract][Full Text] [Related]
13. [Efficacy and safety of treating hyperlipidemia type II with fluvastatin in patients with arterial hypertension]. Rywik S; Kłosiewicz-Latoszek L; Broda G; Szostak WB Pol Merkur Lekarski; 1997 Jul; 3(13):13-6. PubMed ID: 9432291 [TBL] [Abstract][Full Text] [Related]
14. Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage. Smit JW; Jansen GH; de Bruin TW; Erkelens DW Am J Cardiol; 1995 Jul; 76(2):126A-128A. PubMed ID: 7604787 [TBL] [Abstract][Full Text] [Related]
15. Treatment of hypercholesterolemia with fluvastatin in kidney transplant patients. Melchor JL; Gracida C Transplant Proc; 1998 Aug; 30(5):2054. PubMed ID: 9723390 [No Abstract] [Full Text] [Related]
16. Long-term efficacy with fluvastatin as monotherapy and combined with cholestyramine (a 156-week multicenter study). French-Dutch Fluvastatin Study Group. Jacotot B; Banga JD; Waite R; Peters TK Am J Cardiol; 1995 Jul; 76(2):41A-46A. PubMed ID: 7604796 [TBL] [Abstract][Full Text] [Related]
17. Effect of fluvastatin for safely lowering atherogenic lipids in renal transplant patients receiving cyclosporine. Holdaas H; Hartmann A; Stenstrøm J; Dahl KJ; Borge M; Pfister P Am J Cardiol; 1995 Jul; 76(2):102A-106A. PubMed ID: 7604781 [TBL] [Abstract][Full Text] [Related]
18. Comparison of fluvastatin versus pravastatin treatment of primary hypercholesterolemia. French Fluvastatin Study Group. Jacotot B; Benghozi R; Pfister P; Holmes D Am J Cardiol; 1995 Jul; 76(2):54A-56A. PubMed ID: 7604799 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of fluvastatin in patients with non-insulin-dependent diabetes mellitus and hyperlipidemia: preliminary report. Knopp RH; Frolich JJ Am J Cardiol; 1994 May; 73(14):39D-41D. PubMed ID: 8198023 [TBL] [Abstract][Full Text] [Related]